BLPH logo

Bellerophon Therapeutics (BLPH) Selling, General & Administrative Expenses

Annual SGA

$6.02 M
-$1.12 M-15.73%

December 31, 2022

Summary

Performance

1-Year Change

-15.73%

3-Year Change

-6.51%

5-Year Change

-10.72%

15-Year Change

-10.72%

BLPH SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$14.87 M
BLPH annual SGA is currently -59.50% below its historical high of $14.87 million

3-Year Low

$6.02 M
BLPH annual SGA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
BLPH previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
BLPH next annual earnings announcement has not yet been scheduled

OtherBLPHexpensesmetrics:

Annual Total Expenses

$22.38 M
BLPH annual total expenses is $22.38 million

Annual Operating Expenses

$22.38 M
BLPH annual total operating expenses is $22.38 million

Annual Cost Of Goods Sold

-
BLPH annual cost of goods sold value is unknown

Annual Interest Expense

-
BLPH annual interest expense value is unknown

Quarterly SGA

$1.63 M
-$738.00 K-31.22%

September 30, 2023

Summary

Performance

3-Month Change

0%

1-Year Change

+19.03%

3-Year Change

+19.03%

5-Year Change

+2.65%

BLPH Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$4.57 M
BLPH quarterly SGA is currently -64.44% below its historical high of $4.57 million

3-Year Low

$1.11 M
BLPH quarterly SGA is currently +46.35% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
BLPH previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
BLPH next earnings announcement has not yet been scheduled

OtherBLPHexpensesmetrics:

Quarterly Total Expenses

$2.17 M
BLPH quarterly total expenses is $2.17 million

Quarterly Operating Expenses

$2.17 M
BLPH quarterly total operating expenses is $2.17 million

Quarterly Cost Of Goods Sold

-
BLPH quarterly cost of goods sold value is unknown

Quarterly Interest Expense

-
BLPH quarterly interest expense value is unknown

TTM SGA

-$1.01 B
-$9.25 M-0.92%

September 30, 2023

Summary

Performance

3-Month Change

-14624.15%

1-Year Change

-17661.04%

3-Year Change

-17661.04%

5-Year Change

-17661.04%

BLPH TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$95.67 M

3-Year Low

-$1.01 B
BLPH TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
BLPH previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
BLPH next earnings announcement has not yet been scheduled

OtherBLPHexpensesmetrics:

Annual Total Expenses

$22.38 M
BLPH annual total expenses is $22.38 million

Annual Operating Expenses

$22.38 M
BLPH annual total operating expenses is $22.38 million

TTM Cost Of Goods Sold

-
BLPH TTM cost of goods sold value is unknown

TTM Interest Expense

-
BLPH TTM interest expense value is unknown

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$6.02 M
BLPH annual SGA is $6.02 million

Annual Operating Expenses

$22.38 M
BLPH annual total operating expenses is $22.38 million

Annual Cost Of Goods Sold

-
BLPH annual cost of goods sold value is unknown

BLPH Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-15.7%+19.0%-10000.0%
3 y3 years-6.5%+19.0%-10000.0%
5 y5 years-10.7%+2.6%-10000.0%

BLPH Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-15.7%at low-31.2%-31.7%+12.0%at low
5 y5-year-28.2%at low-31.2%-31.7%+37.9%at low
alltimeall time-59.5%at low-64.4%-31.7%+957.9%at low

Bellerophon Therapeutics Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2023
-
$1.63 M(-31.2%)
$6.97 M(+3.9%)
Jun 2023
-
$2.36 M(+46.9%)
$6.71 M(+4.9%)
Mar 2023
-
$1.61 M(+17.5%)
$6.40 M(+6.2%)
Dec 2022
$6.02 M(-15.7%)
$1.37 M(+0.2%)
$6.02 M(+4.5%)
Sep 2022
-
$1.37 M(-33.5%)
$5.76 M(-6.6%)
Jun 2022
-
$2.05 M(+66.5%)
$6.17 M(+1.1%)
Mar 2022
-
$1.23 M(+11.0%)
$6.10 M(-14.6%)
Dec 2021
$7.15 M(-14.8%)
$1.11 M(-37.3%)
$7.15 M(-11.2%)
Sep 2021
-
$1.77 M(-10.8%)
$8.04 M(-5.0%)
Jun 2021
-
$1.99 M(-12.7%)
$8.47 M(-3.7%)
Mar 2021
-
$2.27 M(+13.2%)
$8.79 M(+4.8%)
Dec 2020
$8.39 M(+30.2%)
$2.01 M(-8.5%)
$8.39 M(+6.8%)
Sep 2020
-
$2.20 M(-4.9%)
$7.85 M(+12.4%)
Jun 2020
-
$2.31 M(+23.3%)
$6.99 M(+11.3%)
Mar 2020
-
$1.87 M(+26.8%)
$6.28 M(-2.6%)
Dec 2019
$6.44 M(-15.5%)
$1.48 M(+10.8%)
$6.44 M(-5.7%)
Sep 2019
-
$1.33 M(-16.5%)
$6.83 M(-3.6%)
Jun 2019
-
$1.60 M(-21.6%)
$7.08 M(-6.1%)
Mar 2019
-
$2.04 M(+9.1%)
$7.55 M(-1.0%)
Dec 2018
$7.62 M
$1.87 M(+17.9%)
$7.62 M(-0.7%)
DateAnnualQuarterlyTTM
Sep 2018
-
$1.58 M(-23.0%)
$7.67 M(-2.1%)
Jun 2018
-
$2.06 M(-2.6%)
$7.83 M(+5.7%)
Mar 2018
-
$2.11 M(+10.1%)
$7.41 M(+9.9%)
Dec 2017
$6.75 M(-5.1%)
$1.92 M(+9.9%)
$6.75 M(-3.7%)
Sep 2017
-
$1.75 M(+6.9%)
$7.01 M(+0.0%)
Jun 2017
-
$1.63 M(+13.0%)
$7.01 M(+6.5%)
Mar 2017
-
$1.45 M(-33.7%)
$6.58 M(-7.5%)
Dec 2016
$7.11 M(-52.2%)
$2.18 M(+25.0%)
$7.11 M(-4.7%)
Sep 2016
-
$1.75 M(+44.8%)
$7.46 M(-25.7%)
Jun 2016
-
$1.21 M(-39.0%)
$10.04 M(-18.2%)
Mar 2016
-
$1.98 M(-22.0%)
$12.27 M(-17.5%)
Dec 2015
$14.87 M(+7.9%)
$2.53 M(-41.5%)
$14.87 M(-4.2%)
Sep 2015
-
$4.33 M(+26.0%)
$15.51 M(+2.6%)
Jun 2015
-
$3.44 M(-24.9%)
$15.12 M(-4.8%)
Mar 2015
-
$4.57 M(+43.9%)
$15.88 M(+15.3%)
Dec 2014
$13.78 M(+52.8%)
$3.18 M(-19.2%)
$13.78 M(+2.4%)
Sep 2014
-
$3.93 M(-6.2%)
$13.46 M(+41.3%)
Jun 2014
-
$4.19 M(+69.8%)
$9.52 M(+78.7%)
Mar 2014
-
$2.47 M(-13.6%)
$5.33 M(+86.4%)
Dec 2013
$9.01 M(+25.4%)
$2.86 M
$2.86 M
Dec 2012
$7.18 M
-
-

FAQ

  • What is Bellerophon Therapeutics annual SGA?
  • What is the all time high annual SGA for Bellerophon Therapeutics?
  • What is Bellerophon Therapeutics annual SGA year-on-year change?
  • What is Bellerophon Therapeutics quarterly SGA?
  • What is the all time high quarterly SGA for Bellerophon Therapeutics?
  • What is Bellerophon Therapeutics quarterly SGA year-on-year change?
  • What is Bellerophon Therapeutics TTM SGA?
  • What is the all time high TTM SGA for Bellerophon Therapeutics?
  • What is Bellerophon Therapeutics TTM SGA year-on-year change?

What is Bellerophon Therapeutics annual SGA?

The current annual SGA of BLPH is $6.02 M

What is the all time high annual SGA for Bellerophon Therapeutics?

Bellerophon Therapeutics all-time high annual SGA is $14.87 M

What is Bellerophon Therapeutics annual SGA year-on-year change?

Over the past year, BLPH annual SGA has changed by -$1.12 M (-15.73%)

What is Bellerophon Therapeutics quarterly SGA?

The current quarterly SGA of BLPH is $1.63 M

What is the all time high quarterly SGA for Bellerophon Therapeutics?

Bellerophon Therapeutics all-time high quarterly SGA is $4.57 M

What is Bellerophon Therapeutics quarterly SGA year-on-year change?

Over the past year, BLPH quarterly SGA has changed by +$260.00 K (+19.03%)

What is Bellerophon Therapeutics TTM SGA?

The current TTM SGA of BLPH is -$1.01 B

What is the all time high TTM SGA for Bellerophon Therapeutics?

Bellerophon Therapeutics all-time high TTM SGA is -$95.67 M

What is Bellerophon Therapeutics TTM SGA year-on-year change?

Over the past year, BLPH TTM SGA has changed by -$1.02 B (-17661.04%)